NCT05599113

Brief Summary

The aim of this study is to evaluate the clinical efficacy of Extracorporeal Shock Wave Therapy (ESWT) in patients with Temporomandibular Joint (TMJ) with Reduced Disc Displacement, by comparing it with standard treatment. Scientific Basis and Validity of Medical Research: Temporomandibular Joint Disorders (TMR) are disorders that can cause pain in the head and neck region, limitation in mouth opening, and difficulties even in daily activities (eating, speaking, chewing, yawning, etc.). These disorders have various causes such as malocclusion, emotional stress, parafunctional habits, synovitis, capsulitis, osteoarthritis and intra-articular irregularities. Almost 25% of the world's population has TMJ intra-articular irregularities and these are usually treated with non-surgical methods. If these methods are not successful, surgical treatments are generally used. These non-surgical treatments include many physical therapy interventions such as occlusal splints, medical treatments, bite plates, ultrasound and subcutaneous electrical nerve stimulation, and low-level laser therapies. With these intraorally used occlusal splints, a balanced occlusal contact is achieved without applying any force to the mandible in the resting position. Occlusal splints are available in different designs and different construction materials. The stabilization splint, which is one of the most commonly used occlusal splints, and the modified Hawley splint are appliances produced from hard materials. However, some researchers have commented that soft spints produced from resilient materials may also be useful in the distribution of excessive force formed in parafunctional habits. While there are studies stating that hard splints provide more successful results than soft splints in the functional problems of the chewing system, there are also studies reporting that they have similar efficacy on muscle pain after short-term use. Extracorporeal shock wave therapy (ESWT), another physical therapy modality, used in the treatment of various joint and muscle pains; it is an advantageous treatment modality that is non-invasive, well tolerated by patients and has few side effects. This modality is also used in diseases of the TMJ and masticatory muscles in various sources. The availability of different non-standard treatment regimens and the few studies on the short-term results of ESWT applications make the use of ESWT in the treatment of TMJ diseases still unclear and new studies are needed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2021

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 20, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 31, 2022

Completed
Last Updated

October 31, 2022

Status Verified

October 1, 2022

Enrollment Period

1.1 years

First QC Date

October 20, 2022

Last Update Submit

October 28, 2022

Conditions

Outcome Measures

Primary Outcomes (9)

  • VAS pain score

    A Visual Analogue Scale (VAS) is one of the pain rating scales between 1-10.

    At baseline

  • VAS pain score

    A Visual Analogue Scale (VAS) is one of the pain rating scales between 1-10.

    1 week

  • VAS pain score

    A Visual Analogue Scale (VAS) is one of the pain rating scales between 1-10.

    2 week

  • Painless Maximum Active Mouth Opening

    Measurement with one exception (pain-free opening), every time the patients moves his/her mouth vertically or excursively, he or she is instructed to move it as far as possible in that direction in milimeter.

    At baseline

  • Painless Maximum Active Mouth Opening

    Measurement with one exception (pain-free opening), every time the patients moves his/her mouth vertically or excursively, he or she is instructed to move it as far as possible in that direction in milimeter.

    1 week

  • Painless Maximum Active Mouth Opening

    Measurement with one exception (pain-free opening), every time the patients moves his/her mouth vertically or excursively, he or she is instructed to move it as far as possible in that direction in milimeter.

    2 week

  • Passive Forced Mouth Opening

    Measurement of movements for range of motion and for joint sounds are made with actively pushed on by the examiner in milimeter.

    At baseline

  • Passive Forced Mouth Opening

    Measurement of movements for range of motion and for joint sounds are made with actively pushed on by the examiner in milimeter.

    1 week

  • Passive Forced Mouth Opening

    Measurement of movements for range of motion and for joint sounds are made with actively pushed on by the examiner in milimeter.

    2 week

Study Arms (1)

Extracorporeal Shock Wave Therapy

EXPERIMENTAL

Extracorporeal shock wave therapy (ESWT) is an expedient remedy that is used in various joint and muscle pain treatments, is non-invasive, is well tolerated by patients, and has few side effects.

Device: Extracorporeal Shock Wave Therapy

Interventions

Extracorporeal shock wave therapy (ESWT) is an expedient remedy that is used in various joint and non-invasive muscle pain treatments

Extracorporeal Shock Wave Therapy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with reduced disc displacement according to DC/TMD examination criteria
  • years old
  • No systemic disease that may have effects on masticatory muscles or TMJ
  • Individuals who do not have any tooth loss other than 3. molar teeth and accept the treatments to be done

You may not qualify if:

  • Individuals with total or distal extension partial dentures
  • Individuals who have previously received medical, pharmacological, or any form of treatment for TMD
  • Individuals with recent facial or cervical trauma
  • Individuals with the syndrome who have the potential to affect any component of the stomagnatic system
  • Individuals with parafunctional habits such as clenching or grinding their teeth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beyza Ünalan Değirmenci

Van, 65080, Turkey (Türkiye)

Location

Related Publications (4)

  • Alshihri A. Translational Applications of Extracorporeal Shock Waves in Dental Medicine: A Literature Review. Biomedicines. 2022 Apr 14;10(4):902. doi: 10.3390/biomedicines10040902.

  • Falkensammer F, Arnhart C, Krall C, Schaden W, Freudenthaler J, Bantleon HP. Impact of extracorporeal shock wave therapy (ESWT) on orthodontic tooth movement-a randomized clinical trial. Clin Oral Investig. 2014 Dec;18(9):2187-92. doi: 10.1007/s00784-014-1199-0. Epub 2014 Feb 19.

  • Pfaff JA, Boelck B, Bloch W, Nentwig GH. Growth Factors in Bone Marrow Blood of the Mandible With Application of Extracorporeal Shock Wave Therapy. Implant Dent. 2016 Oct;25(5):606-12. doi: 10.1097/ID.0000000000000452.

  • Keskin Tunc S, Unalan Degirmenci B, Bilen M, Toprak ME, Kaplan S, Turan M. Can extracorporeal shock wave therapy be effective in temporomandibular joint disorder?: A pilot study. Medicine (Baltimore). 2024 Oct 25;103(43):e40052. doi: 10.1097/MD.0000000000040052.

MeSH Terms

Interventions

Extracorporeal Shockwave Therapy

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 20, 2022

First Posted

October 31, 2022

Study Start

January 1, 2020

Primary Completion

January 30, 2021

Study Completion

February 1, 2021

Last Updated

October 31, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations